Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Vaccinia-CEA/Tricom: Phase I

In a U.S. Phase I trial of 58 patients with CEA-bearing cancers, such as colorectal and pancreatic

Read the full 171 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE